Value through Innovation31 October 2014

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

26.10.2012

The Respimat® success story: Boehringer Ingelheim doubles its production capacity

26.10.2012

European approval granted for Trajenta® (linagliptin) tablets as add-on therapy to insulin in adults with Type 2 Diabetes

- For Non-U.S. and Non-U.K. Media
11.10.2012

NICE recommends treatment with alteplase is started as early as possible, within 4.5 hours of onset of ischaemic stroke symptoms

- For non-US media only
11.10.2012

Boehringer Ingelheim congratulates Nobel Prize winner Prof. Brian Kobilka

04.10.2012

Final Phase IIb interferon-free hepatitis C data from Boehringer Ingelheim to be presented at AASLD

- For media outside of the U.S.A. only
02.10.2012

Analyses presented at EASD support Trajenta® (linagliptin) as effective and well-tolerated for patients with type 2 diabetes with different background therapies

- EX US & UK. Medical Media Only.
02.10.2012

Lilly and Boehringer Ingelheim Present Health Outcomes Data for Investigational Novel Basal Insulin Analogue

02.10.2012

Clinical data for investigational SGLT2 inhibitor, empagliflozin*, demonstrates potential for oral treatment in type 2 diabetes

- EX US & UK. Medical Media Only.
01.10.2012

Boehringer Ingelheim’s novel project transfer program enables fast track to launch for biopharmaceuticals

28.09.2012

Unprecedented progression-free survival benefit with afatinib* associated with clinically meaningful improvements in life-limiting lung cancer symptoms and better quality of life

- For NON-US media only
28.09.2012

Join the mission on World Heart Day 2012: call for signatures

27.09.2012

Change in the Board of Managing Directors at Boehringer Ingelheim

27.09.2012

Boehringer Ingelheim opens European Veterinary Research Center in Hanover

24.09.2012

New data from Boehringer Ingelheim and Lilly showcase strength of Diabetes Alliance at EASD Annual Meeting

- EX US & UK Medical Media Only
24.09.2012

Recruitment complete for two pivotal Phase III studies of nintedanib* in patients with idiopathic pulmonary fibrosis

- For NON-U.S Health Media Only
21.09.2012

CHMP recommends indication for the use of Trajenta® (linagliptin) tablets as add-on therapy to insulin in adults with Type 2 Diabetes in Europe

- For Non-U.S. and Non-UK Media
20.09.2012

Boehringer Ingelheim submits first oncology compound, afatinib* for European approval

- For NON-US media only
14.09.2012

Boehringer Ingelheim launches beta social game Syrum to promote science and innovation

- For Non-US and Non-Canadian Media Only